middle.news
Mesoblast adds FDA approved potency test to Ryoncil manufacturing
9:52am on Thursday 24th of September, 2026 AEST
•
Biotechnology
Read Story
Mesoblast adds FDA approved potency test to Ryoncil manufacturing
9:52am on Thursday 24th of September, 2026 AEST
Key Points
FDA approves T-cell Proliferation Inhibition BioAssay for Ryoncil
New test joins two existing commercial potency assays
Designed to detect potency shifts during manufacturing changes
No financial impact, production volumes or assay results disclosed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mesoblast (ASX:MSB)
OPEN ARTICLE